Aug 27, 2026 · 10 min · 7 segments
Send us Fan Mail The hidden gap in cancer care—and the off-label cancer treatments that the average cancer patient will never hear about. 👉 Get…
No entities detected.
Jay ChaplinHost
Look, if a pharma company is doing $100 billion in business and they come up with something that's a cure instead of a treatment and they can only get $10 billion for it, they'd still rather get $10 billion instead of $100 billion.

And you know why? Because any other pharma company that gets to that same treatment, gets to that same cure, they're going to corner the market.

And I guarantee you a pharma company, just like you, would rather have 10 billion instead of nothing because it's not a hundred billion versus 10 billion it's 10 billion versus nothing and again such things don't exist because every cancer is different there is no cure for cancer just like there's no cure for people every person is different every person that you deal with has a different personality you have to treat them all differently just the way that everybody cancer is different So there is no cure for cancer and pharma companies will get money wherever they can.

Case in point, there is a cancer drug, a chemotherapy drug called mitomycin C. I can show you the Memorial Sloan Kettering price sheet for that.

What's a dose of mitomycin C cost? What does the pharma company get for a dose of mitomycin C? Two bucks! Two dollars! If you actually look at chemo, and we'll do a whole other episode about this in the near future because I find it interesting, the economics of cancer are difficult.

Literally having an infusion done in your home with a traveling infusion service can save you a quarter to a third on your entire cancer treatment cost because the drugs aren't it.

Look, if a pharma company is doing $100 billion in business and they come up with something that's a cure instead of a treatment and they can only get $10 billion for it, they'd still rather get $10 billion instead of $100 billion.

And you know why? Because any other pharma company that gets to that same treatment, gets to that same cure, they're going to corner the market.

And I guarantee you a pharma company, just like you, would rather have 10 billion instead of nothing because it's not a hundred billion versus 10 billion it's 10 billion versus nothing and again such things don't exist because every cancer is different there is no cure for cancer just like there's no cure for people every person is different every person that you deal with has a different personality you have to treat them all differently just the way that everybody cancer is different So there is no cure for cancer and pharma companies will get money wherever they can.

Case in point, there is a cancer drug, a chemotherapy drug called mitomycin C. I can show you the Memorial Sloan Kettering price sheet for that.

What's a dose of mitomycin C cost? What does the pharma company get for a dose of mitomycin C? Two bucks! Two dollars! If you actually look at chemo, and we'll do a whole other episode about this in the near future because I find it interesting, the economics of cancer are difficult.

Literally having an infusion done in your home with a traveling infusion service can save you a quarter to a third on your entire cancer treatment cost because the drugs aren't it.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.